Business Context and Reporting Period
This Form 8-K is filed by Sema4 Holdings Corp. (Note: Request metadata lists "Genedx Holdings Corp.", but the filing text identifies the registrant as Sema4 Holdings Corp.) on March 14, 2022, reporting events occurring on March 10, 2022. The filing announces the release of financial results for the year ended December 31, 2021, and addresses a material restatement of prior financial periods.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained in the referenced Press Release (Exhibit 99.1) and Earnings Presentation (Exhibit 99.2), which are not included in the provided text.
Material Changes and Restatements
The Company identified material adjustments requiring the restatement of audited financial statements for the years ended December 31, 2020 and 2019, as well as unaudited interim periods in 2021 and 2020. The specific adjustments include:
- Reclassification of certain genetic counseling department expenses from "cost of services" to "selling and marketing."
- Correction of the timing of cost of services recognition for the quarters ended March 31, June 30, and September 30, 2021.
Consequently, previously issued financial statements for these periods can no longer be relied upon.
Guidance, Outlook, and Management Commentary
Management, in consultation with the Audit Committee and independent auditors Ernst & Young LLP, concluded that the restatements are necessary due to the materiality of the adjustments. The Company stated it will include the restated financial statements in its Annual Report on Form 10-K for the year ended December 31, 2021, filed on March 14, 2022. No specific forward-looking guidance or outlook is provided in this text.
Investor Verification Checklist
- Verify the specific financial impact of the expense reclassification and timing adjustments in the restated 10-K.
- Review the March 14, 2022 Press Release (Exhibit 99.1) for actual 2021 revenue and loss figures.
- Confirm the updated liquidity position and cash burn rate in the new 10-K filing.
- Assess the implications of the restatement on the Company's internal controls and accounting processes.